Transcriptional activation of Mina by Sp1/3 factors

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Lian, Shangli ^a   Potula, Hari Hara S K ^a   Pillai, Meenu R ^a   Van Stry, Melanie ^a   Koyanagi, Madoka ^a   Chung, Linda ^a   Watanabe, Makiko ^a   Bix, Mark ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REGULATOR PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3;

5' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA FLANKING REGION; ENHANCER REGION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE REGULATORY NETWORK; GENETIC VARIABILITY; GENOMIC FRAGMENT; INTRON; MINA GENE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PNEUMONIA; PROMOTER REGION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE SPECIFICITY; TRANSCRIPTION INITIATION; TUMOR IMMUNITY;

ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENHANCER ELEMENTS, GENETIC; EPIGENESIS, GENETIC; GENES, REPORTER; LUCIFERASES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RNA, SMALL INTERFERING; SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ACTIVATION;

EID: 84891860126     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080638     Document Type: Article

References (39)

1. Okamoto M, Van Stry M, Chung L, Koyanagi M, Sun X, et al. (2009) Mina, an Il4 repressor, controls T helper type 2 bias. Nature Immunology 10: 872-879.
2. Tsuneoka M, Koda Y, Soejima M, Teye K, Kimura H (2002) A novel myc target gene, mina53, that is involved in cell proliferation. J Biol Chem 277: 35450-35459.
3. Zhang Y, Lu Y, Yuan BZ, Castranova V, Shi X, et al. (2005) The Human mineral dust-induced gene, mdig, is a cell growth regulating gene associated with lung cancer. Oncogene 24: 4873-4882.
4. Teye K, Tsuneoka M, Arima N, Koda Y, Nakamura Y, et al. (2004) Increased expression of a Myc target gene Mina53 in human colon cancer. Am J Pathol 164: 205-216.
5. Kuratomi K, Kusukawa J (2006) Immunohistochemical expression of Mina53 and Ki67 proteins in human primary gingival squamous cell carcinoma. The Kurume medical journal 53: 71-78.
6. Tsuneoka M, Fujita H, Arima N, Teye K, Okamura T, et al. (2004) Mina53 as a potential prognostic factor for esophageal squamous cell carcinoma. Clin Cancer Res 10: 7347-7356.
7. Ishizaki H, Yano H, Ogasawara S, Akiba J, Nishida N, et al. (2007) Overexpression of the myc target gene Mina53 in advanced renal cell carcinoma. Pathol Int 57: 672-680.
8. Teye K, Arima N, Nakamura Y, Sakamoto K, Sueoka E, et al. (2007) Expression of Myc target gene mina53 in subtypes of human lymphoma. Oncol Rep 18: 841-848.
9. Fukahori S, Yano H, Tsuneoka M, Tanaka Y, Yagi M, et al. (2007) Immunohistochemical expressions of Cap43 and Mina53 proteins in neuroblastoma. J Pediatr Surg 42: 1831-1840.
10. Zhang Q, Hu CM, Yuan YS, He CH, Zhao Q, et al. (2008) Expression of Mina53 and its significance in gastric carcinoma. Int J Biol Markers 23: 83-88.
11. Ogasawara S, Komuta M, Nakashima O, Akiba J, Tsuneoka M, et al. (2010) Accelerated expression of a Myc target gene Mina53 in aggressive hepatocellular carcinoma. Hepatol Res 40: 330-336.
12. Komiya K, Sueoka-Aragane N, Sato A, Hisatomi T, Sakuragi T, et al. (2010) Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer. Lung Cancer 69: 232-238.
13. Komiya K, Sueoka-Aragane N, Sato A, Hisatomi T, Sakuragi T, et al. (2010) Mina53, a novel c-Myc target gene, is frequently expressed in lung cancers and exerts oncogenic property in NIH/3T3 cells. J Cancer Res Clin Oncol 136: 465-473.
14. Yosef N, Shalek AK, Gaublomme JT, Jin H, Lee Y, et al. (2013) Dynamic regulatory network controlling TH17 cell differentiation. Nature 496: 461-468.
15. Giresi PG, Lieb JD (2009) Isolation of active regulatory elements from eukaryotic chromatin using FAIRE (Formaldehyde Assisted Isolation of Regulatory Elements). Methods 48: 233-239.
16. Tone Y, Kojima Y, Furuuchi K, Brady M, Yashiro-Ohtani Y, et al. (2007) OX40 gene expression is up-regulated by chromatin remodeling in its promoter region containing Sp1/Sp3, YY1, and NF-kappa B binding sites. J Immunol 179: 1760-1767.
17. Blume SW, Snyder RC, Ray R, Thomas S, Koller CA, et al. (1991) Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J Clin Invest 88: 1613-1621.
18. Kouzarides T (2007) Chromatin modifications and their function. Cell 128: 693-705.
19. Goldberg AD, Allis CD, Bernstein E (2007) Epigenetics: a landscape takes shape. Cell 128: 635-638.
20. Suganuma T, Workman JL (2011) Signals and combinatorial functions of histone modifications. Annu Rev Biochem 80: 473-499.
21. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, et al. (2006) A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125: 315-326.
22. Thierry-Mieg D, Thierry-Mieg J (2006) AceView: a comprehensive cDNA-supported gene and transcripts annotation. Genome Biol 7 Suppl 1: S12 11-14.
23. Morris JF, Rauscher FJ, 3rd, Davis B, Klemsz M, Xu D, et al. (1995) The myeloid zinc finger gene, MZF-1, regulates the CD34 promoter in vitro. Blood 86: 3640-3647.
24. Emili A, Greenblatt J, Ingles CJ (1994) Species-specific interaction of the glutamine-rich activation domains of Sp1 with the TATA box-binding protein. Mol Cell Biol 14: 1582-1593.
25. Hoey T, Weinzierl RO, Gill G, Chen JL, Dynlacht BD, et al. (1993) Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators. Cell 72: 247-260.
26. Gill G, Pascal E, Tseng ZH, Tjian R (1994) A glutamine-rich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of the Drosophila TFIID complex and mediates transcriptional activation. Proc Natl Acad Sci U S A 91: 192-196.
27. Lania L, Majello B, De Luca P (1997) Transcriptional regulation by the Sp family proteins. Int J Biochem Cell Biol 29: 1313-1323.
28. Kumar AP, Butler AP (1999) Enhanced Sp1 DNA-binding activity in murine keratinocyte cell lines and epidermal tumors. Cancer Lett 137: 159-165.
29. Black AR, Black JD, Azizkhan-Clifford J (2001) Sp1 and kruppel-like factor family of transcription factors in cell growth regulation and cancer. J Cell Physiol 188: 143-160.
30. Wang L, Wei D, Huang S, Peng Z, Le X, et al. (2003) Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin Cancer Res 9: 6371-6380.
31. Pore N, Liu S, Shu HK, Li B, Haas-Kogan D, et al. (2004) Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism. Mol Biol Cell 15: 4841-4853.
32. Arai N, Naito Y, Watanabe M, Masuda ES, Yamaguchi-Iwai Y, et al. (1992) Activation of lymphokine genes in T cells: role of cis-acting DNA elements that respond to T cell activation signals. Pharmacol Ther 55: 303-318.
33. Brightbill HD, Plevy SE, Modlin RL, Smale ST (2000) A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages. J Immunol 164: 1940-1951.
34. Tone M, Powell MJ, Tone Y, Thompson SA, Waldmann H (2000) IL-10 gene expression is controlled by the transcription factors Sp1 and Sp3. J Immunol 165: 286-291.
35. Hummelshoj T, Ryder LP, Madsen HO, Odum N, Svejgaard A (2006) A functional polymorphism in the Eta-1 promoter is associated with allele specific binding to the transcription factor Sp1 and elevated gene expression. Mol Immunol 43: 980-986.
36. Dzialo-Hatton R, Milbrandt J, Hockett RD, Jr., Weaver CT (2001) Differential expression of Fas ligand in Th1 and Th2 cells is regulated by early growth response gene and NF-AT family members. J Immunol 166: 4534-4542.
37. Chen GY, Osada H, Santamaria-Babi LF, Kannagi R (2006) Interaction of GATA-3/T-bet transcription factors regulates expression of sialyl Lewis X homing receptors on Th1/Th2 lymphocytes. Proc Natl Acad Sci U S A 103: 16894-16899.
38. Dorado B, Martin-Saavedra FM, Jerez MJ, Ballester S (2006) The activity of interleukin-4 receptor alpha-chain promoter is regulated by a GT box element. Mol Immunol 43: 1808-1816.
39. Xin ZT, Carroll KA, Kumar N, Song K, Ly H (2011) Transcriptional activation of TINF2, a gene encoding the telomere-associated protein TIN2, by Sp1 and NF-kappaB factors. PLoS One 6: e21333.